Aliases for APOBEC3F Gene
- Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3F 2 3 5
- Apolipoprotein B MRNA-Editing Enzyme Catalytic Polypeptide-Like 3F 3 4
- A3F 3 4
- Apolipoprotein B MRNA Editing Enzyme, Catalytic Polypeptide-Like 3F 2
- Apolipoprotein B Editing Enzyme Catalytic Polypeptide-Like 3F 3
- Apolipoprotein B MRNA Editing Enzyme Cytidine Deaminase 3
- DNA DC->DU-Editing Enzyme APOBEC-3F 3
External Ids for APOBEC3F Gene
Previous GeneCards Identifiers for APOBEC3F Gene
This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
GeneCards Summary for APOBEC3F Gene
APOBEC3F (Apolipoprotein B MRNA Editing Enzyme Catalytic Subunit 3F) is a Protein Coding gene. Diseases associated with APOBEC3F include Theileriasis and Hiv-1. GO annotations related to this gene include poly(A) RNA binding and hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines. An important paralog of this gene is APOBEC3D.
UniProtKB/Swiss-Prot for APOBEC3F Gene
DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Exhibits antiviral activity against vif-deficient HIV-1. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA. Exhibits antiviral activity also against hepatitis B virus (HBV), equine infectious anemia virus (EIAV), xenotropic MuLV-related virus (XMRV) and simian foamy virus (SFV) and may inhibit the mobility of LTR and non-LTR retrotransposons. May also play a role in the epigenetic regulation of gene expression through the process of active DNA demethylation.